ImmunologybioRxiv
Cell therapy with IL-10-producing group 2 innate lymphoid cells suppresses Graft-versus-Host disease
K. T. Reid, S. J. Colpitts, J. A. Mathews…·S. Q. Crome
This study demonstrates that IL-10-producing group 2 innate lymphoid cells (ILC210) can suppress Graft-versus-Host Disease (GVHD) in a humanized model without compromising graft-versus-leukemic effects.
DOI 10.1016/j.celrep.2024.115102